NEXTWAVE PHARMACEUTICALS
Live / Registered — Registered and renewed (as of 18 Mar 2024)
What this means for you
Registered since 29 Oct 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Oct 2023).
Record
- Serial number
- 85406355
- Registration number
- 4425993
- Mark type
- Stylized text
- Filed
- 24 Aug 2011
- Published for opposition
- 07 Feb 2012
- Registered
- 29 Oct 2013
- Next maintenance due
- 29 Oct 2023
- Attorney of record
- Cathy A. Kodroff
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment [ of hypertension; pharmaceuticals ] for the treatment of attention deficit hyperactivity disorder (ADHD); [ pharmaceuticals for the treatment of cardiovascular diseases; ] pharmaceuticals for the treatment of central nervous system diseases
Owner
- NextWave Pharmaceuticals Incorporated, Monmouth Junction, NJ, US
- NextWave Pharmaceuticals Incorporated, Cupertino, CA, US
- NextWave Pharmaceuticals Incorporated, Cupertino, CA, US
Prosecution history
- 18 Mar 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 18 Mar 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 18 Mar 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 18 Mar 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Oct 2023 — TEAS SECTION 8 & 9 RECEIVED
- 29 Oct 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 01 Dec 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 01 Dec 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Dec 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Oct 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Oct 2019 — TEAS SECTION 8 & 15 RECEIVED
- 05 Feb 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Feb 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Oct 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Oct 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY